Susan B. Stewart - Apr 11, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Regulatory Officer
Signature
/s/ John Canepa, as Attorney-In-Fact for Susan B. Stewart
Stock symbol
CADL
Transactions as of
Apr 11, 2022
Transactions value $
$0
Form type
4
Date filed
4/12/2022, 05:15 PM
Previous filing
Jul 26, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +20K $0.00 20K Apr 11, 2022 Common Stock 20K $5.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on May 11, 2022, subject to the Reporting Person's continued service on each such vesting date.